Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF

被引：0
|
作者：
M Tanaka
T Yujiri
Y Tanaka
N Mitani
A Tanimura
Y Tanizawa
机构：
[1] Yamaguchi University Graduate School of Medicine,Department of Bio
[2] Yamaguchi University School of Medicine,Signal Analysis
来源：
Bone Marrow Transplantation | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1143 / 1144
页数：1
相关论文
共 50 条
  • [1] Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF
    Tanaka, M.
    Yujiri, T.
    Tanaka, Y.
    Mitani, N.
    Tanimura, A.
    Tanizawa, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 (08) : 1143 - 1144
  • [2] PBSC mobilization efficacy of G-CSF 16 μg/kg/day:: analysis of 175 healthy donors
    Koristek, Z.
    Mayer, J.
    Navratil, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S309 - S310
  • [3] Mobilization of healthy donors with G-CSF for allogenic transplant with peripheral blood stem cell (PBSC)
    Beléndez, C
    Regidor, C
    Sanjuán, I
    Forés, R
    Marcos, M
    Fernández, P
    Lago, M
    Cabrera, R
    Briz, M
    Bañas, H
    Peñalver, FJ
    Barbolla, L
    Fernández, MN
    BONE MARROW TRANSPLANTATION, 1998, 21 : S191 - S191
  • [4] Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs
    Platzbecker, U
    Prange-Krex, G
    Bornhäuser, M
    Koch, R
    Soucek, S
    Aikele, P
    Haack, A
    Haag, C
    Schuler, U
    Berndt, A
    Rutt, C
    Ehninger, G
    Hölig, K
    TRANSFUSION, 2001, 41 (02) : 184 - 189
  • [5] Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors
    Schmitt, M.
    Xu, X.
    Hilgendorf, I.
    Schneider, C.
    Borchert, K.
    Glaeser, D.
    Freund, M.
    Schmitt, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 922 - 925
  • [6] Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors
    M Schmitt
    X Xu
    I Hilgendorf
    C Schneider
    K Borchert
    D Gläser
    M Freund
    A Schmitt
    Bone Marrow Transplantation, 2013, 48 : 922 - 925
  • [7] Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
    Terpos, Evangelos
    Heath, Deborah J.
    Rahemtulla, Amin
    Zervas, Kostas
    Chantry, Andrew
    Anagnostopoulos, Athanasios
    Pouli, Anastasia
    Katodritou, Eirini
    Verrou, Evgenia
    Vervessou, Elisavet-Christine
    Dimopoulos, Meletios-Athanassios
    Croucher, Peter I.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (05) : 688 - 692
  • [8] Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors
    Wei, S
    Teitelbaum, SL
    Wang, MWH
    Ross, FP
    ENDOCRINOLOGY, 2001, 142 (03) : 1290 - 1295
  • [9] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults
    Jung, K
    Lein, M
    Von Hösslin, K
    Grosse, A
    Roth, S
    Possinger, K
    Lüftner, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
  • [10] Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)
    Terpos, Evangelos
    Christoulas, Dimitrios
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (11) : 1265 - 1269
12345